ATE246708T1 - Elatase-inhibitoren - Google Patents

Elatase-inhibitoren

Info

Publication number
ATE246708T1
ATE246708T1 AT95918993T AT95918993T ATE246708T1 AT E246708 T1 ATE246708 T1 AT E246708T1 AT 95918993 T AT95918993 T AT 95918993T AT 95918993 T AT95918993 T AT 95918993T AT E246708 T1 ATE246708 T1 AT E246708T1
Authority
AT
Austria
Prior art keywords
inhibitors
elatase
elastase
compounds
human neutrophil
Prior art date
Application number
AT95918993T
Other languages
English (en)
Inventor
William A Metz Jr
Steven L Gallion
Joseph P Burkhart
Michael R Angelastro
Norton P Peet
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of ATE246708T1 publication Critical patent/ATE246708T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95918993T 1994-06-02 1995-05-05 Elatase-inhibitoren ATE246708T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25279994A 1994-06-02 1994-06-02
PCT/US1995/005618 WO1995033763A1 (en) 1994-06-02 1995-05-05 Novel elastase inhibitors

Publications (1)

Publication Number Publication Date
ATE246708T1 true ATE246708T1 (de) 2003-08-15

Family

ID=22957608

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95918993T ATE246708T1 (de) 1994-06-02 1995-05-05 Elatase-inhibitoren

Country Status (20)

Country Link
EP (1) EP0804465B1 (de)
JP (1) JP3623799B2 (de)
KR (1) KR100347285B1 (de)
CN (1) CN1149877A (de)
AT (1) ATE246708T1 (de)
AU (1) AU689589B2 (de)
CA (1) CA2189527C (de)
DE (1) DE69531459T2 (de)
DK (1) DK0804465T3 (de)
ES (1) ES2199992T3 (de)
FI (1) FI964781A7 (de)
HU (1) HU221197B1 (de)
IL (1) IL113940A (de)
NO (1) NO965097L (de)
NZ (1) NZ285565A (de)
PT (1) PT804465E (de)
SI (1) SI0804465T1 (de)
TW (1) TW403762B (de)
WO (1) WO1995033763A1 (de)
ZA (1) ZA954430B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ284766A (en) * 1994-06-02 1998-06-26 Merrell Pharma Inc Perfluoro amino ketones; medicaments as elastase inhibitors
DE69522940T2 (de) * 1994-06-02 2002-04-04 Merrell Pharmaceuticals Inc., Cincinnati Acylierte enolderivate als vorläufdrogen von elastaseinhibitoren
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
US6767991B1 (en) 1997-08-11 2004-07-27 Boehringer Ingelheim (Canada) Ltd. Hepatitis C inhibitor peptides
CL2004001161A1 (es) 2003-05-21 2005-04-08 Boehringer Ingelheim Int Compuestos describe compuestos derivados de quinolina; composicion farmaceutica; y su uso para tratar una enfermedad causada por el virus de la hepatitis c.
UY29016A1 (es) 2004-07-20 2006-02-24 Boehringer Ingelheim Int Analogos de dipeptidos inhibidores de la hepatitis c
JP4914355B2 (ja) 2004-07-20 2012-04-11 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃ型肝炎インヒビターペプチド類似体
CA2651762A1 (en) 2006-05-23 2007-11-29 Irm Llc Compounds and compositions as channel activating protease inhibitors
AU2008214217B2 (en) * 2007-02-09 2011-10-13 Irm Llc Compounds and compositions as channel activating protease inhibitors
JP7672641B2 (ja) 2019-09-17 2025-05-08 メレオ バイオファーマ ４ リミテッド 移植片拒絶反応、閉塞性細気管支炎症候群、及び移植片対宿主病の治療に使用するためのアルベレスタット
IL297211B2 (en) 2020-04-16 2025-12-01 Mereo Biopharma 4 Ltd Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
KR20240090272A (ko) 2021-10-20 2024-06-21 메레오 바이오파마 4 리미티드 섬유화 치료에 사용하기 위한 호중구 엘라스테이스 억제제

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
ATE71934T1 (de) * 1985-06-07 1992-02-15 Ici America Inc Selektionierte difluorverbindungen.
ZA905737B (en) * 1989-07-26 1991-05-29 Merrell Dow Pharma Novel peptidase inhibitors
WO1992012140A1 (en) * 1990-12-28 1992-07-23 Georgia Tech Research Corporation Peptides ketoamides, ketoacids, and ketoesters
ZA926185B (en) * 1991-08-22 1993-03-01 Merrell Dow Pharma Novel orally-active elastase inhibitors.

Also Published As

Publication number Publication date
FI964781L (fi) 1997-01-29
NZ285565A (en) 1998-08-26
CA2189527A1 (en) 1995-12-14
AU2470995A (en) 1996-01-04
CN1149877A (zh) 1997-05-14
NO965097L (no) 1997-01-31
DE69531459T2 (de) 2004-06-24
AU689589B2 (en) 1998-04-02
ES2199992T3 (es) 2004-03-01
JPH10500992A (ja) 1998-01-27
HU9603312D0 (en) 1997-01-28
TW403762B (en) 2000-09-01
KR100347285B1 (ko) 2003-01-15
DE69531459D1 (de) 2003-09-11
FI964781A0 (fi) 1996-11-29
WO1995033763A1 (en) 1995-12-14
ZA954430B (en) 1996-02-13
EP0804465B1 (de) 2003-08-06
FI964781A7 (fi) 1997-01-29
NO965097D0 (no) 1996-11-29
EP0804465A1 (de) 1997-11-05
JP3623799B2 (ja) 2005-02-23
DK0804465T3 (da) 2003-11-24
IL113940A0 (en) 1995-08-31
SI0804465T1 (en) 2003-12-31
HU221197B1 (en) 2002-08-28
CA2189527C (en) 2000-12-19
IL113940A (en) 1999-12-31
MX9606030A (es) 1998-05-31
PT804465E (pt) 2003-12-31
HUT76926A (hu) 1998-01-28

Similar Documents

Publication Publication Date Title
NO307968B1 (no) Pyrazolo- og pyrrolopyridiner og farmasøytisk blanding derav
BG101841A (bg) Инхибитори на клетъчна адхезия
DK0793674T3 (da) Inhibitorer af human neutrofil elastase
TR200000059T2 (tr) Piridin türevleri
BR9710737A (pt) Pentafluorobenzenosulfonamidas e análogos.
DE69920757D1 (de) Immunsuppressive wirkungen von pteridinderivaten
ES2192839T3 (es) Timosina beta 4 oxidada.
ATE246708T1 (de) Elatase-inhibitoren
DK0489877T3 (da) Antiatherosklerotiske og antithrombotiske 2-amino-6-phenyl-4H-pyran-4-oner
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
ATE265455T1 (de) Tetrahydropyridoverbindungen
ES2140672T3 (es) Compuestos biciclicos sustituidos, fusionados y puentes utilizados como agentes terapeuticos.
AP2000001760A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
BRPI0415355A (pt) triarilimidazóis
NO20005548L (no) Mykobakterieinhibitorer
DE69726743D1 (de) Peptid analoge, die einen siebengliedrigen lactamring enthalten
EA200100152A1 (ru) Замещенные пиперазиноны и их терапевтическое применение
FI972673A7 (fi) 4,4-(disubstituoitu)sykloheksan-1-oli-monomeereja ja vastaavia yhdiste itä
EA199800822A1 (ru) Способ лечения избыточной агрессии
TR200003083T2 (tr) CNS hastalıklarının tedavisi için paroxetine 10-camphorsulfonate.
PE61999A1 (es) Compuestos de tetrahidropiridina

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0804465

Country of ref document: EP

REN Ceased due to non-payment of the annual fee